Good morning. Today's lecture concerns CRISPR-Cas9, a revolutionary gene-editing technology transforming genetic engineering.  CRISPR, derived from a bacterial defense mechanism, utilizes a guide RNA molecule to direct the Cas9 enzyme to a specific DNA sequence.  This targeted location is then cleaved, allowing for precise gene modification.  This precision represents a significant advancement over previous methods, offering greater efficiency and reduced off-target effects.

The implications are vast. In medicine, CRISPR holds immense potential for treating genetic diseases like cystic fibrosis and sickle cell anemia through direct gene correction within somatic cells.  Furthermore, ongoing research explores its use in cancer immunotherapy by engineering immune cells to more effectively target cancerous tissue.  Beyond human health, CRISPR finds application in agriculture, facilitating the development of crops with enhanced yields, nutritional content, and pest resistance.  Ethical considerations, however, remain paramount, demanding rigorous oversight and responsible application of this powerful technology.  Further research is crucial to refine techniques and mitigate potential risks.